TMSB10 and tuberculosis: The IFN-γ responses of the control group (Fig. 1B) were nearly equivalent at the mean after stimulation with ACR/Rv1733/Rv2626 and TB10.4/ESAT6/CFP10 (209.9 ± 412.8 mlU/ml vs.177.9 ± 283.6 mlU/ml), but significantly inferior compared to the IFN-γ response in patients with tuberculosis disease after stimulation with ACR/Rv1733/Rv2626 (209.9 ± 412.8 mlU/ml vs. 329.7 ± 477.6 mlU/ml, p = 0.012) and TB10.4/ESAT6/CFP10 (177.9 ± 283.6 mlU/ml vs. 2,651 ± 4,506 mlU/ml, p = < 0.0001).